MEDVIDA Partners announces that yesterday it completed its acquisition of Metrópolis’ life insurance portfolio. The transaction is an important milestone in Spain and for MEDVIDA Partners as it represents the first transfer of life insurance savings with-profits portfolios between unrelated entities. The solution implemented by MEDVIDA Partners results in an economically sound mechanism for both […]
The Spanish regulator has approved the merger of Mediterráneo Vida (MEDVIDA) and MEDVIDA Partners (formerly CNP Partners), acquired by the group in 2022. The merged company, which manages close to €3.5 billion in assets, reaffirms its appetite for making further acquisitions of life insurance businesses in Spain. MEDVIDA Partners has announced that the management team […]
MEDVIDA has reached an agreement with VidaCaixa whereby it will transfer part of Sa Nostra Vida’s life insurance portfolio. The transaction which is now subject to regulatory approval by the Directorate General of Insurance and Pension Funds (DGSFP) and expected to be completed during the first half of next year, is limited to the portfolio […]
Madrid, 3rd January 2023.- MEDVIDA has appointed Jaime Kirkpatrick as Managing Director of CNP Partners, which has been renamed MEDVIDA Partners, having completed the purchase of 100% of the company on 29th December 2022. Jaime Kirkpatrick joined MEDVIDA in September last year to prepare for the integration and business transformation of CNP Partners. Jaime was […]
Madrid, 19th December 2022.- After signing the sale and purchase agreement last May, MEDVIDA last week received the final regulatory approvals for its acquisition of CNP Partners. The transaction marks an important milestone for MEDVIDA in its long-term strategy to grow and consolidate life insurance operations in Europe. Antonio Trueba, CEO of MEDVIDA, commented: “We […]
Madrid, December 7, 2022. MEDVIDA has priced a new issuance of Tier 2 subordinated debt amounting to 21 million euros. The debt is expected to be subscribed for and paid up during December 2022, subject to entering into a subscription agreement and the other agreements relating to the issue, and subject to compliance with the […]
Madrid, July 28, 2022.- Mediterráneo Vida (MedVida) has successfully issued €30m of subordinated debt maturing in January 2033 to optimise its capital position and support its growth plans including the acquisition of CNPP Partners and the Metropolis life insurance portfolio. Through the issue, MedVida welcomes several new international investors as capital providers. The significant interest […]
The new director of the insurance company was until last June responsible for insurance services at Deloitte Spain and EMEA. Madrid, July 26, 2022 – Mediterráneo Vida (MedVida) has appointed Jordi Montalbo Todolí, a renowned professional with more than 30 years of experience in the insurance sector, to its board of directors. The new director […]
Madrid, July 1, 2022.- Metrópolis confirmed yesterday a portfolio transfer of its life insurance business to Mediterráneo Vida (MedVida). The transaction is subject to regulatory approvals and is expected to be completed by the end of this year. With this transaction, Metrópolis completes its corporate restructuring, ceasing its insurance underwriting activity to focus on its […]
Madrid, 5 May 2022.- Mediterráneo Vida (MedVida) has signed terms to acquire CNP Partners, the Spanish subsidiary of the French group CNP Assurances. The sale and purchase agreement was signed today and MedVida is expected to take effective control of CNP Partners in the fourth quarter of 2022, following regulatory approvals. With this acquisition MedVida […]